
( Brand: Hemosure ), ( Manufacturer Part Number: T1-CK30 ), ( Part Type: Blood Test )
The T1-CK30 HemoSure iFOBT 30 is an immunochemical fecal occult blood test (iFOBT) designed for the qualitative detection of human hemoglobin in fecal specimens. This product is manufactured by Tulip Diagnostics, a globally recognized name in the field of in-vitro diagnostics.
The T1-CK30 kit includes 30 individual test cups, each designed to accommodate a single fecal sample. The test cups are pre-filled with a specific reagent that reacts with human hemoglobin, making it easy for healthcare professionals to perform the test. The test cups are made of high-quality, FDA-approved materials to ensure safety and reliability.
The test is simple to perform. A patient collects a fecal sample using the provided collection kit, and then applies the sample to the corresponding test cup. The sample is then mixed with the reagent in the test cup, and the resulting color change is compared to a color chart provided with the kit. If the color change matches the color chart's indication of a positive result, it suggests the presence of occult blood in the sample.
The T1-CK30 HemoSure iFOBT 2019-04 is a valuable tool for screening for colorectal cancer and other gastrointestinal disorders. Its easy-to-use design and reliable results make it a popular choice among healthcare professionals. The kit comes with a detailed user manual to ensure proper use and interpretation of results.
In conclusion, the T1-CK30 HemoSure iFOBT 30 is a reliable and user-friendly test for detecting occult blood in fecal specimens. Its pre-filled test cups, simple test procedure, and color chart for result interpretation make it an ideal choice for healthcare professionals. The product's 2019-04 manufacturing date ensures that it is of the latest technology and meets the highest quality standards.
Pros of buying T1-CK30 HemoSure IFOB 30 Immunochemical Fecal Occult Blood Tests (2019-04):1. High Sensitivity: The T1-CK30 HemoSure IFOB 30 test has a high sensitivity, which means it can detect small amounts of blood in the stool, making it an effective tool for screening for colorectal cancer.
2. Simple and Non-Invasive: The test is easy to use and does not require any invasive procedures, making it a convenient option for individuals who are uncomfortable with more invasive tests.
3. Accurate Results: The T1-CK30 HemoSure IFOB 30 test is a reliable option for detecting fecal occult blood, providing accurate results that can help doctors make informed decisions about further diagnostic tests.
4. Cost-Effective: Compared to other colorectal cancer screening methods, the T1-CK30 HemoSure IFOB 30 test is a cost-effective option that can help individuals save money on medical expenses.
Cons of buying T1-CK30 HemoSure IFOB 30 Immunochemical Fecal Occult Blood Tests (2019-04):1. False Positives: The T1-CK30 HemoSure IFOB 30 test can produce false positive results, which means that it may indicate the presence of blood when none is actually present. This can lead to unnecessary follow-up tests and anxiety for individuals.
2. False Negatives: While the T1-CK30 HemoSure IFOB 30 test has a high sensitivity, it is not 100% accurate, and there is a risk of false negatives. This means that the test may fail to detect the presence of blood in the stool, even if it is present.
3. Limited Use: The T1-CK30 HemoSure IFOB 30 test is only intended for use as a screening tool for colorectal cancer and should not be used as a diagnostic tool. If a positive result is obtained, further diagnostic tests should be performed to confirm the diagnosis.
Conclusion:The T1-CK30 HemoSure IFOB 30 Immunochemical Fecal Occult Blood Tests (2019-04) is a useful tool for screening for colorectal cancer, as it is easy to use, non-invasive, and has a high sensitivity. However, it is important to note that false positives and false negatives are possible, and individuals should not rely on the test as a sole means of diagnosing colorectal cancer. If a positive result is obtained, further diagnostic tests should be performed to confirm the diagnosis. Overall, the T1-CK30 HemoSure IFOB 30 test can be a cost-effective option for individuals looking to screen for colorectal cancer, but it should be used as part of a broader approach to cancer screening and prevention.
Recommendation:Individuals who are at increased risk of colorectal cancer, such as those with a family history of the disease, should consider undergoing regular screening using the T1-CK30 HemoSure IFOB 30 test or other screening methods recommended by their healthcare provider. Regular screening can help detect colorectal cancer at an early stage, when it is more treatable, and reduce the risk of death from the disease. In addition to regular screening, individuals should also adopt healthy lifestyle habits, such as eating a balanced diet, exercising regularly, and avoiding tobacco and excessive alcohol consumption, to reduce their risk of developing colorectal cancer.